Search results
Found 30060 matches for
A review of public comments on a proposed FDA regulatory framework, for modifications to artificial intelligence and machine learning-based software as a medical device, has found that 63% came from parties with financial ties to industry, and that the majority, 86% did not cite any scientific evidence.
Meet the team
-
Gary Collins
Professor of Medical Statistics and Director of CSM
-
Andrew Carr
Nuffield Professor of Orthopaedics
Funded by
